Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 3/20 | 0.49 |
| ▸ | FNTB | P49356 | 3/20 | 0.49 |
| ▸ | MAPKAPK2 | P49137 | 8/20 | 0.49 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7255227 | 0.93 | CYP11B1 (0.48) | FNTAFNTBMAPKAPK2 | |
| SCHEMBL7259737 | 0.92 | FNTA (0.51) | FNTAFNTBMAPKAPK2PGGT1B | |
| SCHEMBL7255275 | 0.91 | MAPKAPK2 (0.45) | FNTAFNTBMAPKAPK2PGGT1B | |
| SCHEMBL7258754 | 0.90 | FNTA (0.48) | FNTAFNTBMAPKAPK2 | |
| SCHEMBL7255069 | 0.86 | CYP11B1 (0.49) | FNTAFNTBMAPKAPK2PGGT1B | |
| SCHEMBL6708505 | 0.85 | MAPKAPK2 (0.52) | MAPKAPK2 | |
| SCHEMBL7255218 | 0.84 | CYP11B1 (0.48) | FNTAFNTBMAPKAPK2PGGT1B | |
| SCHEMBL7255257 | 0.84 | FNTA (0.46) | FNTAFNTBMAPKAPK2PGGT1B | |
| SCHEMBL7256035 | 0.84 | FNTA (0.51) | FNTAFNTBPGGT1B | |
| SCHEMBL7259654 | 0.83 | CYP11B1 (0.41) | FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003099812-A1 | PHENYL-FURAN OR PHENYL-THIOPHENE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINE | PIERRE FABRE MEDICAMENT (FR) | 2003-12-04 | — | — | WO | claimed |
| WO-2003099812-A1 | PHENYL-FURAN OR PHENYL-THIOPHENE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS MEDICINE | PIERRE FABRE MEDICAMENT (FR) | 2003-12-04 | — | — | WO | disclosed |